Your browser doesn't support javascript.
loading
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.
Heffernan, Michele L R; Herman, Lee W; Brown, Scott; Jones, Philip G; Shao, Liming; Hewitt, Michael C; Campbell, John E; Dedic, Nina; Hopkins, Seth C; Koblan, Kenneth S; Xie, Linghong.
Afiliación
  • Heffernan MLR; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Herman LW; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Brown S; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Jones PG; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Shao L; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Hewitt MC; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Campbell JE; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Dedic N; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Hopkins SC; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Koblan KS; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
  • Xie L; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts 01752, United States.
ACS Med Chem Lett ; 13(1): 92-98, 2022 Jan 13.
Article en En | MEDLINE | ID: mdl-35047111

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos